nach oben

Erschienen in:

01.07.2021 | News item

HPRA publishes important safety information on dinoprostone

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

The Irish Health Products Regulatory Authority (HPRA) has published important safety information from Ferring Ireland and Pfizer Healthcare Ireland on dinoprostone products marketed in Ireland (PROPESS and PROSTIN, respectively). …

HPRA. DINOPROSTONE - Important Safety Information from Ferring Ireland Limited and Pfizer Healthcare Ireland of products containing Dinoprostone as approved by the HPRA Internet Document : 25 Jun 2021. Available from: URL: https://www.hpra.ie/homepage/medicines/safety-notices/item?t=/dinoprostone---important-safety-information-from-ferring-ireland-limited-and-pfizer-healthcare-ireland-of-products-containing-dinoprostone-as-approved-by-the-hpra&id=7fcf0f26-9782-6eee-9b55-ff00008c97d0

Titel: HPRA publishes important safety information on dinoprostone
Publikationsdatum: 01.07.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-98606-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

HPRA publishes important safety information on dinoprostone

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Dabigatran-etexilate

Ethiodized-oil

Amikacin

Methylprednisolone/prednisolone

Canagliflozin/dapagliflozin

Adalimumab